Lim Bryant David 4
4 · Prelude Therapeutics Inc · Filed May 16, 2024
Insider Transaction Report
Form 4
Lim Bryant David
CLO, CFO, Corp Sec.
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-05-14+25,000→ 25,000 totalExercise: $3.86Exp: 2034-05-13→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on May 14, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.